NCT05973318View on ClinicalTrials.gov

Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

September 17, 2018

Study Completion Date

September 17, 2018

Conditions

Primary Open Angle Glaucoma of Both Eyes

Interventions

DRUG

Dorzotimol eye drops, 20 mg/mL + 5 mg/mL

Dosing schedule b.i.d.

DRUG

Cosopt eye drops, 20 mg/mL + 5 mg/mL

Dosing schedule b.i.d.

Trial Locations (1)

Unknown

Republican Clinical Ophthalmological Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan'

All Listed Sponsors

lead

Jadran Galenski laboratorij d.d.

INDUSTRY

NCT05973318 - Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL | Biotech Hunter | Biotech Hunter